Cargando…
Differential Diagnosis and Clinical Management of a Case of COVID-19 in a Patient With Stage III Lung Cancer Treated With Radio-chemotherapy and Durvalumab
Autores principales: | Guerini, Andrea Emanuele, Borghetti, Paolo, Filippi, Andrea Riccardo, Bonù, Marco Lorenzo, Tomasini, Davide, Greco, Diana, Imbrescia, Jessica, Volpi, Giulia, Triggiani, Luca, Borghesi, Andrea, Maroldi, Roberto, Pasinetti, Nadia, Buglione, Michela, Magrini, Stefano Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7265852/ https://www.ncbi.nlm.nih.gov/pubmed/32527714 http://dx.doi.org/10.1016/j.cllc.2020.05.027 |
Ejemplares similares
-
Unresectable stage III non-small cell lung cancer: could durvalumab be safe and effective in real-life clinical scenarios? Results of a single-center experience
por: Borghetti, Paolo, et al.
Publicado: (2023) -
Mebendazole as a Candidate for Drug Repurposing in Oncology: An Extensive Review of Current Literature
por: Guerini, Andrea Emanuele, et al.
Publicado: (2019) -
RR Myelo POINT: A Retrospective Single-Center Study Assessing the Role of Radiotherapy in the Management of Multiple Myeloma and Possible Interactions with Concurrent Systemic Treatment
por: Guerini, Andrea Emanuele, et al.
Publicado: (2022) -
Two months of radiation oncology in the heart of Italian “red zone” during COVID-19 pandemic: paving a safe path over thin ice
por: Buglione, Michela, et al.
Publicado: (2020) -
Chemo-radiotherapy plus durvalumab for loco-regional relapse of resected NSCLC
por: Borghetti, Paolo, et al.
Publicado: (2022)